Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1980 Dec;41(4):865–873.

Use of the ELISA to screen for anti-thymocyte and anti-beta 2-microglobulin antibodies in leprosy and SLE.

G M Bahr, G A Rook, E Moreno, P M Lydyard, F Z Modabber, J L Stanford
PMCID: PMC1458311  PMID: 6161879

Abstract

A report is given of the use of the enzyme-linked immunosorbent assay to measure antibody to preparations of human thymocyte membranes (HTMA) and to beta 2-microglobulin. The assay described is simple and rapid, and requires only small quantities of an easily stored membrane preparation. The advantages of this technique over conventional methods involving cytotoxicity are discussed. Raised levels of IgM antibody to beta 2-microglobulin were detected in sera from SLE patients. Raised levels of IgG and IgM antibody to HTMA were found in sera from most active lepromatous cases. Two of eight sera from SLE patients showed raised IgG anti-HMTA, but not raised IgM. An attempt was made to study the subclass of the IgG antibodies found, but when checked against purified human IgG myeloma proteins, the available anti-subclass sera were found to lack the necessary degree of specificity in this assay.

Full text

PDF
868

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bjune G., Barnetson R. S. Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions. Clin Exp Immunol. 1976 Dec;26(3):397–402. [PMC free article] [PubMed] [Google Scholar]
  2. Crumpton M. J., Snary D. Preparation and properties of lymphocyte plasma membrane. Contemp Top Mol Immunol. 1974;3:27–56. doi: 10.1007/978-1-4684-2838-4_2. [DOI] [PubMed] [Google Scholar]
  3. ENGELFRIET C. P., EIJSVOOGEL V. P. CYTOTOXIC ISO-ANTIBODIES AGAINST LEUCOCYTES. Vox Sang. 1965 Mar-Apr;10:228–233. doi: 10.1111/j.1423-0410.1965.tb04345.x. [DOI] [PubMed] [Google Scholar]
  4. Fanger M. W., Bernier G. M. Subpopulations of human lymphocytes defined by 2 -microglobulin. J Immunol. 1973 Aug;111(2):609–617. [PubMed] [Google Scholar]
  5. Finnie A., Mason M., Muir C. Evaluation of the RAHA test for rheumatoid factor. Med Lab Technol. 1974 Oct;31(4):323–326. [PubMed] [Google Scholar]
  6. Goldblum R., Pillarisetty R., Talal N. Independent appearance of anti-thymocyte and anti-RNA antibodies in NZB/NZW F1 mice. Immunology. 1975 Apr;28(4):621–628. [PMC free article] [PubMed] [Google Scholar]
  7. Horwitz D. A., Garrett M. A., Craig A. H. Serum effects of mitogenic reactivity in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Technical considerations and lack of correlation with anti-lymphocyte antibodies. Clin Exp Immunol. 1977 Jan;27(1):100–110. [PMC free article] [PubMed] [Google Scholar]
  8. Kin K., Kasahara T., Itoh Y., Sakurabayashi I., Kawai T., Morita K. Cellular cooperation in lymphocyte activation. II. Cooperative response of human peripheral T and B lymphocytes to rabbit anti-human beta 2-microglobulin. Clin Exp Immunol. 1979 May;36(2):292–298. [PMC free article] [PubMed] [Google Scholar]
  9. Kreisler M., Naito S., Terasaki P. I. Cytotoxins in disease. V. Various diseases. Transplant Proc. 1971 Mar;3(1):112–114. [PubMed] [Google Scholar]
  10. Matthews L. J., Trautman J. R. Clinical and serological profiles in leprosy. Lancet. 1965 Nov 6;2(7419):915–917. doi: 10.1016/s0140-6736(65)92899-0. [DOI] [PubMed] [Google Scholar]
  11. McAdam K. P., Fudenberg H. H., Michaeli D. Antibodies to collagen in patients with leprosy. Clin Immunol Immunopathol. 1978 Jan;9(1):16–21. doi: 10.1016/0090-1229(78)90115-0. [DOI] [PubMed] [Google Scholar]
  12. Messner R. P., Kennedy M. S., Jelinek J. G. Antilymphocyte antibodies in systemic lupus erythematosus. Effect on lymphocyte surface characteristics. Arthritis Rheum. 1975 May-Jun;18(3):201–206. doi: 10.1002/art.1780180302. [DOI] [PubMed] [Google Scholar]
  13. Mittal K. K., Mickey M. R., Singal D. P., Terasaki P. I. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968 Nov;6(8):913–927. doi: 10.1097/00007890-196811000-00006. [DOI] [PubMed] [Google Scholar]
  14. Morimoto C., Abe T., Toguchi T., Kiyotaki M., Homma M. Studies of anti-lymphocyte antibody of patients with active SLE. I. Cause of loss of suppressor T-lymphocyte function. Scand J Immunol. 1979;10(3):213–221. doi: 10.1111/j.1365-3083.1979.tb01342.x. [DOI] [PubMed] [Google Scholar]
  15. Nelson D. S., Penrose J. M., Waters M. F., Pearson J. M., Nelson M. Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment. Clin Exp Immunol. 1975 Dec;22(3):385–392. [PMC free article] [PubMed] [Google Scholar]
  16. Ooi B. S., Ooi Y. M., Pesce A. J., Pollak V. E. Antibodies to beta 2 microglobulin in the sera of patients with systemic lupus erythematosus. Immunology. 1977 Oct;33(4):535–541. [PMC free article] [PubMed] [Google Scholar]
  17. PAYNE R., ROLFS M. R. Fetomaternal leukocyte incompatibility. J Clin Invest. 1958 Dec;37(12):1756–1763. doi: 10.1172/JCI103768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Plesner T., Wiik A. Demonstration of electrophoretic heterogeneity of serum beta 2-microglobulin in systemic lupus erythematosus and rheumatoid arthritis: evidence against autoantibodies to beta 2-microglobulin. Scand J Immunol. 1979 Mar;9(3):247–254. doi: 10.1111/j.1365-3083.1979.tb02728.x. [DOI] [PubMed] [Google Scholar]
  19. Revillard J. P., Vincent C., Rivera S. Anti-beta2-microglobulin lymphocytotoxic autoantibodies in systemic lupus erythematosus. J Immunol. 1979 Feb;122(2):614–618. [PubMed] [Google Scholar]
  20. Stastny P., Ziff M. Antibodies against cell membrane constituents in systemic lupus erythematosus and related diseases. I. Cytotoxic effect of serum from patients with systemic lupus erythematosus (SLE) for allogeneic and for autologous lymphocytes. Clin Exp Immunol. 1971 Apr;8(4):543–550. [PMC free article] [PubMed] [Google Scholar]
  21. Twomey J. J., Laughter A. H., Steinberg A. D. A serum inhibitor of immune regulation in patients with systemic lupus erythematosus. J Clin Invest. 1978 Sep;62(3):713–715. doi: 10.1172/JCI109180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wager O. Immunological aspects of leprosy with special reference to autoimmune diseases. Bull World Health Organ. 1969;41(6):793–804. [PMC free article] [PubMed] [Google Scholar]
  23. Wernet P., Kunkel H. G. Antibodies to a specific surface antigen of T cells in human sera inhibiting mixed leukocyte culture reactions. J Exp Med. 1973 Oct 1;138(4):1021–1026. doi: 10.1084/jem.138.4.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Winfield J. B., Winchester R. J., Wernet P., Fu S. M., Kunkel H. G. Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus. Arthritis Rheum. 1975 Jan-Feb;18(1):1–8. doi: 10.1002/art.1780180101. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES